605507.SS
Guobang Pharma Ltd. [605507.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
605507.SS Stock Summary
Top 10 Correlated ETFs
605507.SS
Top 10 Correlated Stocks
605507.SS
In the News
605507.SS Financial details
Company Rating
-
Market Cap
8.65B
Income
688.91M
Revenue
5.66B
Book val./share
-
Cash/share
-
Dividend
0.6
Dividend %
3.51%
Employees
3.71K
Optionable
No
Shortable
Yes
Earnings
18 Oct 2023
P/E
13.63
Forward P/E
-
PEG
-85.87
P/S
1.69
P/B
1.28
P/C
-
P/FCF
-13.88
Quick Ratio
1.84
Current Ratio
2.49
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.24
EPS next Y
-
EPS next Q
-
EPS this Y
30.95%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
30.26%
Revenue last 5Y
11.77%
Revenue Q/Q
-11.13%
EPS Q/Q
-17.24%
-
-
-
-
SMA20
9.52%
SMA50
15%
SMA100
15%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
10%
ROC
0.1%
Gross Margin
25%
Oper. Margin
14%
Profit Margin
12%
Payout
52%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
13.01-25.17
52W High
-6.52%
52W Low
+79.77%
RSI
63
Rel Volume
2.57
Avg Volume
2.48M
Volume
6.35M
Perf Week
1.13%
Perf Month
15.01%
Perf Quarter
18.69%
Perf Half Y
14.95%
-
-
-
-
Beta
0.289
-
-
Volatility
0.11%, 1.29%
Prev Close
0.91%
Price
23.37
Change
0.17%
605507.SS Financial Performance
605507.SS Frequently Asked Questions
What is Guobang Pharma Ltd. stock symbol ?
Guobang Pharma Ltd. is a CN stock and trading under the symbol 605507.SS
What is Guobang Pharma Ltd. stock quote today ?
Guobang Pharma Ltd. stock price is $23.37 today.
Is Guobang Pharma Ltd. stock public?
Yes, Guobang Pharma Ltd. is a publicly traded company.
Company Profile
- Volume Average 2.48M
- Market Capitalization 8.65B
- Employee 3.71K
- CEO Mr. Yuda Gong
- Headquarters Xinchang,CN
- IPO Date 2021-08-02
-
Website
https://www.gbgcn.com 
Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations. The company was founded in 1996 and is based in Xinchang, China.
